Clinical trial digitization Aparito specializes in digitizing clinical trials through the Atom5 platform using video assessments, wearables, and ePROs to generate real-world data. This positions them as a partner for sponsors seeking remote, patient-centric trial solutions and faster data collection.

Life-limiting disease focus The company targets patients with life-limiting diseases, aligning with sponsors pursuing innovative therapies and rare disease indications, where real-world patient data and remote monitoring can de-risk trials and support regulatory submissions.

Strategic partnerships Aparito has a track record of collaborations with academic institutions, humanitarian projects, and industry groups, signaling openness to co-development and multi-stakeholder initiatives that can extend reach, credibility, and access to diverse patient populations.

Industry recognition Awards and finalist status in STEM innovation and health technology, plus a EURORDIS Company Award, enhance credibility with buyers and payers, helping to accelerate engagement with pharmaceutical sponsors and biotech scale-ups.

Growth and ecosystem With a lean team and operations under Eli Lilly and Company, Aparito demonstrates potential for scale through enterprise-grade cloud and tech stack (Azure, Terraform, Docker) while offering opportunities to integrate with larger biopharma programs and data platforms.